Novo Nordisk A/S Class B Overview

Novo Nordisk A/S Class B Total Revenue

Revenue analysis for NONOF.

Quarterly Revenue

$96.82B

↑ 23.99% YoY

As of Mar 2026

Annual Revenue (TTM)

$327.62B

↑ 8.08% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Total Revenue History

Total Revenue Comparison

Annual Revenue Growth Rate (%)

Annual Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin